MEDIA POLICY

EMBARGO POLICY

CX 2022 embargoes information (particularly results, data and conclusions) presented from publication and any public dissemination of, including on social media channels such as Linkedin or Twitter until after the end of that session. Sessions consist of groups of talks, so a talk may take place at 09:10 within an hour-long session, meaning the embargo is lifted when that session ends at 10:00 (for example). All times will be listed in Greenwich Mean Time (GMT).

SOCIAL MEDIA POLICY

CX 2022 accepts comments and discussions via our social media outlets related to vascular education. We do not solicit nor endorse any comment which may be posted, and comments, likes, or follows do not express the opinion or views of CX. We will remove any information, discussion, comment, and material that we deem to be inappropriate and/or which violates our policy to protect patient identities. All content or commentary with a promotional purpose for a service, device, or technology will be removed immediately. CX assumes no liability for information posted or presented by outside parties, and only endorses comments and postings provided directly by CX.

Please use the hashtag #CX2022

PHOTOGRAPHY, VIDEO RECORDING, AND AUDIO RECORDING

Any posting or live streaming of entire sessions or live cases and use of any CX 2022 content for commercial purposes is strictly prohibited.

NEWS RELEASE POLICY

  • All news releases must abide by CX 2022’s embargo policy and should not be released prior to the embargo date and time.
  • Press releases should reference CX 2022 or the CX Symposium in the body of the release, preferably in the first paragraph. Suggested language is provided below.
  • We cannot review industry press releases in advance of the meeting.

CX Contact: info@cxsymposium.com

SUGGESTED LANGUAGE FOR CX 2022

We encourage in-person attendance but for those who are unable to attend in-person, the event will be livestreamed. Our mission is to raise vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus, after discussion with an expert audience.